BMS Archive

Fungi · Scientific monograph

Fomes fomentarius

Hoof Fungus / Tinder Conk

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Inflammatory Pathways, Oxidative Stress Research, Microbial Research

Research overview

Historical use

One of the oldest known medicinal fungi, used by humans for at least 5,300 years — a piece was found in the toolkit of Ötzi the Iceman (Alpine mummy, c. 3,300 BCE), likely used as a fire-starting material and possibly for medicinal purposes. Used in European folk medicine for wound healing, as a haemostatic agent, and to treat digestive disorders. The amadou (processed inner tissue) was used historically as tinder, clothing, and wound dressings.

Modern research context

Contemporary research has confirmed antioxidant, anti-inflammatory, antimicrobial, and cytotoxic properties. Insoluble extracted fibres from the fruiting body demonstrate immunological activity relevant to nutraceutical applications [1]. Melanin-glucan complex shows anti-infective properties against bacterial and viral pathogens [2]. Ethanol extracts inhibit cell growth and induce apoptosis in cancer cell lines in vitro [3]. Antimicrobial activity against a range of pathogens has been confirmed in vitro [4]. Fermented extracellular polysaccharides exhibit antioxidant properties [5]. Human clinical data remain absent; biomaterial and wound-care applications are an emerging research focus.

Adverse effects

Insufficient human clinical data to characterise adverse effects fully. No significant toxicity reported in preclinical studies. Theoretical bleeding risk with concentrated extracts.

Contraindications

No well-established clinical contraindications have been identified, primarily due to the absence of human clinical data. Anticoagulants — theoretical additive anticoagulant activity warrants avoidance of concurrent use. Use during pregnancy and lactation is not recommended due to insufficient clinical safety data.

Clinical and phytochemical data

Used part

Fruiting body (conk), particularly the inner trama tissue (amadou)

Primary active compounds

  • Fomentariol (triterpenoid)

  • Fomentosan (beta-glucan polysaccharide)

  • Hispidin (styrylpyrone)

  • Lanostane triterpenoids

  • Phenolic compounds (protocatechuic acid, caffeic acid)

Mechanism of action

Hispidin and fomentariol act as potent antioxidants (radical scavenging via phenolic hydroxyl groups). Fomentariol inhibits topoisomerase II, inducing cancer cell cycle arrest (G2/M phase). Polysaccharide fractions activate Dectin-1/TLR-4, promoting IL-12 and TNF-α secretion. Anticoagulant activity through inhibition of thrombin and platelet aggregation.

Pharmacokinetics

Absorption

Absorption is compound-dependent. Protocatechuic acid (PCA), a phenolic acid present in Fomes fomentarius alongside caffeic acid, is absorbed in healthy humans after oral dosing; plasma concentrations were quantified following single and multiple oral doses in 12 healthy subjects [1]. No human data exist for fomentariol, hispidin, or the fomentosan polysaccharide — No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — No human PK data available. Phenolic compounds expected to have moderate oral absorption; triterpenoids limited due to poor water solubility.

Distribution

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Fomentariol and hispidin are phenolic compounds with moderate lipophilicity; distribute systemically after intestinal absorption. Polysaccharide fractions concentrate in GALT and spleen. No formal human pharmacokinetic distribution data; all available data from in vitro and rodent studies.

Metabolism

No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Assumed hepatic phase I/II metabolism of phenolic and triterpenoid compounds based on analogous structures.

Excretion

Urinary excretion of protocatechuic acid was measured in healthy human subjects, enabling characterisation of renal clearance as part of a full single- and multiple-dose PK study [1]. No human excretion data exist for other Fomes fomentarius constituents — No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Assumed primarily biliary/fecal for triterpenoids; renal for phenolic metabolites.

Safety and interactions

Drug interactions

Lack of clinical studies prevents interaction grading. Unknown safety profile with concomitant drug use.

Toxicity

LD50 not established in humans. No significant organ toxicity in preclinical studies at normal doses. Amadou (physical material) used as wound dressing is non-toxic.

Special precautions

Pregnancy

No human clinical safety data are available. Use during pregnancy is not recommended due to the absence of established safety information.

Lactation

No human clinical safety data are available. Excretion of constituents into breast milk has not been studied. Use during breastfeeding is not recommended due to insufficient safety information.

Hepatic impairment

No hepatotoxicity documented. No data in hepatic impairment.

Renal impairment

No data available. Standard caution applies.

Sources and references

  1. [1] - Kalitukha L., "Medicinal Potential of the Insoluble Extracted Fibers Isolated from the Fomes fomentarius Fruiting Body.", Int J Med Mushrooms, 2023, PMID: 37017659
  2. [2] - Seniuk OF., "Anti-infective properties of the melanin-glucan complex obtained from medicinal tinder bracket mushroom, Fomes fomentarius.", Int J Med Mushrooms, 2011, PMID: 22135899
  3. [3] - Lee SO., "Fomes fomentarius Ethanol Extract Exerts Inhibition of Cell Growth and Motility Induction through the Suppression of Focal Adhesion Kinase.", Int J Mol Sci, 2019, PMID: 30845749
  4. [4] - Doğan HH., "Fomes fomentarius and Tricholoma anatolicum (Agaricomycetes) Extracts Exhibit Significant Antimicrobial Activity.", Int J Med Mushrooms, 2020, PMID: 32478999
  5. [5] - Zhang Q., "Optimization of fermentation of Fomes fomentarius extracellular polysaccharide and antioxidant activity.", Cell Mol Biol (Noisy-le-grand), 2020, PMID: 33287923

Additional source links

Continue browsing